Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial-Reference-Cited by-同舟云学术

Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial

Published:2024-05-28 Issue:9 Volume:241 Page:1905-1914
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Zali Alireza,Hajyani Shirin,Salari Mehri,Tajabadi-Ebrahimi Maryam^ORCID,Mortazavian Amir M.,Pakpour Bahareh

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00213-024-06606-9.pdf

Reference43 articles.

1. Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM (2013) Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord 19:218–221

2. Açar Y, Ağagündüz D, De Cicco P, Capasso R (2023) Flavonoids: their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease. Biomed Pharmacother 168:115788

3. Azzam AY, Ghozy S, Azab MA (2022) Vitamin D and its’ role in Parkinson’s disease patients with SARS-CoV-2 infection. A review article. Interdiscip Neurosurg 27:101441

4. Barati M, Jabbari M, Nickho H, Esparvarinha M, Javadi Mamaghani A, Majdi H, Fathollahi A, Davoodi SH (2021) Regulatory T cells in bioactive peptides-Induced oral tolerance; a two-edged Sword related to the risk of chronic diseases: a systematic review. Nutr Cancer 73:956–967

5. Barichella M, Garri F, Caronni S, Bolliri C, Zocchi L, Macchione MC, Ferri V, Calandrella D, Pezzoli G (2022) Vitamin D Status and Parkinson’s Disease. Brain Sci, 12